Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|June 24, 2013
- June 2013
- Volume 17
- Issue 1
Parents Ignore Warning Labels on Cough Medicine
Advertisement
The latest University of Michigan Mott Children’s Hospital National Poll on Children’s Health reveals that more than 40% of parents give children under 4 years old multi-symptom cough and cold medicine, despite warning labels. Researchers also found that 25% of parents give children under 4 years old decongestants.
Articles in this issue
over 13 years ago
Pain Control: Using Nonprescription Analgesicsover 13 years ago
US-Born Children Have More Asthma, Allergies Than Immigrant Peersover 13 years ago
Finding Effective Relief for Constipationover 13 years ago
Multiple Factors Linked to Readmission After GI Surgeryover 13 years ago
Case Studies in Self-Careover 13 years ago
Multivitamin/Multimineral Supplement Useover 13 years ago
Acetaminophen Helps Death Fearsover 13 years ago
2012-2013 The Medical Year in Reviewover 13 years ago
Pharmacy Times: Leading the Wayover 13 years ago
Activity Helps Hot Flashes & Night SweatsAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Pharmacists can explain the evidence supporting the intramuscular injection, address specific concerns, and help families understand what is known—and what is not known—about oral vitamin K.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5